LISCure and Celltrion to develop novel microbiome treatment for Parkinson’s disease
Korean startup LISCure Biosciences Inc. enters into a multi-year strategic R&D collaboration with Celltrion to identify novel microbiome therapy for ...
KoreaTechDesk | Korean Startup and Technology News
Korean startup LISCure Biosciences Inc. enters into a multi-year strategic R&D collaboration with Celltrion to identify novel microbiome therapy for ...
The microbiome treatment market is receiving global attention and is rapidly emerging as a new treatment alternative for various intractable ...